Hiroki Izumi

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Venues

Cancer research communications

The Journal of experimental medicine

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Respirology case reports

Hino Hospital

Tottori University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hino Hospital Oct 01 2016

Japan

M.D. :: Internal Medicine

Tottori Kenritsu Chuo Byoin Mar 01 2015 - Sep 30 2016

Japan

M.D. :: Department of Respiratory Medicine

Tottori University Apr 01 2011 - Feb 28 2015

Japan

The Division of Medical Oncology and Molecular Respirology

Matsue Sekijuji Byoin Apr 01 2009 - Mar 31 2011

Japan

Resident

Education History

Tottori University Apr 01 2011 - Mar 31 2015

Japan

PHD :: Graduate School of Medicine

Publications

Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, Maria Eugenia Olmedo, Michael J Boyer, Kai He, Neeltje Steeghs, Hiroki Izumi, Melissa Lynne Johnson, Tatsuya Yoshida, Hasna Bouchaab, Hossein Borghaei, Enriqueta Felip Font, Philipp J Jost, Shirish M Gadgeel, Xi Chen, Youfei Yu, Pablo Martinez, Amanda Parkes, Luis G Paz-Ares
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Makoto Nishio, Shuji Murakami, Hiasto Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications 4 (1) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Makoto Nishio, Shuji Murakami, Hiasto Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications 4 (1) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Makoto Nishio, Shuji Murakami, Hiasto Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma
Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Zhen Qin, Meiting Yue, Shijie Tang, Feng-Ying Wu, Honghua Sun, Yuan Li, Yong-Chang Zhang, Hiroki Izumi, Hsin-Yi Huang, Wanying Wang, Yun Xue, Xinyuan Tong, Shunta Mori, Tetsuro Taki, Koichi Goto, Yujuan Jin, Fei Li, Fu-Ming Li, Yijun Gao, Zhaoyuan Fang, Yisheng Fang, Liang Hu, Xiumin Yan, Guo-Liang Xu, Haiquan Chen, Susumu S Kobayashi, Andrea Ventura, Kwok-Kin Wong, Xueliang Zhu, Liang Chen, Shengxiang Ren, Luo-Nan Chen, Hongbin Ji
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation. The Journal of experimental medicine 221 (3) (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A Kinome-Wide Synthetic Lethal CRISPR/Cas9 Screen Reveals That mTOR Inhibition Prevents Adaptive Resistance to CDK4/CDK6 Blockade in HNSCC. Cancer research communications 4 (7) (2024)
Yusuke Goto, Keiichi Koshizuka, Toshinori Ando, Hiroki Izumi, Xingyu Wu, Kuniaki Sato, Tomohiko Ishikawa, Kyle Ford, Xiaodong Feng, Zhiyong Wang, Nadia Arang, Michael M Allevato, Ayush Kishore, Prashant Mali, Jorge Silvio Gutkind
A kinome-wide synthetic lethal CRISPR/Cas9 screen reveals that mTOR inhibition prevents adaptive resistance to CDK4/CDK6 blockade in HNSCC. Cancer research communications (2024)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a First-In-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small Cell Lung Cancer: An Open-Label, Phase I Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Luis G Paz-Ares, Stephane Champiat, W Victoria Lai, Hiroki Izumi, Ramaswamy Govindan, Michael J Boyer, Horst-Dieter Hummel, Hossein Borghaei, Melissa Lynne Johnson, Neeltje Steeghs, Fiona Blackhall, Afshin Dowlati, Noemí Reguart, Tatsuya Yoshida, Kai He, Shirish M Gadgeel, Enriqueta Felip Font, Yiran Zhang, Amrita Pati, Mukul Minocha, Sujoy Mukherjee, Amanda Goldrick, Dirk Nagorsen, Nooshin Hashemi Sadraei, Taofeek Kunle Owonikoko
Tarlatamab, a first-in-class DLL3-targeted bispecific T cell engager, in recurrent small-cell lung cancer: an open-label, phase 1 study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Akira Sugimoto, Shingo Matsumoto, Hibiki Udagawa, Ryo Itotani, Yuko Usui, Shigeki Umemura, Kazumi Nishino, Ichiro Nakachi, Shoichi Kuyama, Haruko Daga, Satoshi Hara, Shingo Miyamoto, Terufumi Kato, Jun Sakakibara Konishi, Eriko Tabata, Taku Nakagawa, Tomoya Kawaguchi, Tetsuya Sakai, Yuji Shibata, Hiroki Izumi, Kaname Nosaki, Yoshitaka Zenke, Kiyotaka Yoh, Koichi Goto
A large-scale prospective concordance study of plasma- and tissue-based next-generation targeted sequencing for advanced non-small cell lung cancer (LC-SCRUM-Liquid). Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Hiroki Izumi, Zhiyong Wang, Yusuke Goto, Toshinori Ando, Xingyu Wu, Xuefeng Zhang, Hua Li, Daniel E Johnson, Jennifer R Grandis, J Silvio Gutkind
Pathway-Specific Genome Editing of PI3K/mTOR Tumor Suppressor Genes Reveals that PTEN Loss Contributes to Cetuximab Resistance in Head and Neck Cancer. Molecular cancer therapeutics 19 (7) (2020)
Hiroki Izumi, Masahiro Kodani, Shingo Matsumoto, Yuji Kawasaki, Tadashi Igishi, Eiji Shimizu
A case of lung abscess successfully treated by transbronchial drainage using a guide sheath. Respirology case reports 5 (3) (2017)

Hiroki Izumi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroki Izumi